CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The METAcancer project focuses on identifying molecular biomarkers for breast cancer by analyzing metabolite changes associated with tumor development. Using advanced profiling technologies, it aims to create a diagnostic system that combines metabolomic and transcriptomic data for better prognosis and targeted therapi…
Breast cancer is the most common cancer in women.
It is therefore in the focus of approaches for the identification of predictive molecular biomarkers.
In contrast to transcriptomics, the changes in metabolite levels that are associated with tumor development and progression have not been investigated to a great extent, so far.
Metabolomics is defined as the study of all metabolites in a cell, tissue or organism, and the metabolome is regarded as the amplified output of a biological system.
The…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
United Kingdom, Cambridge
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United States, OAKLAND CA
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
Germany, NEU-ISENBURG
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
